Patent · US Active

Benzoxazinone amides as mineralocorticoid receptor modulators

US9394291B2 · kind B2 · utility

4Cited by

0References

5Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Gavin O'Mahony · Timrå, SE
Michael Kossenjans · Mölndal, SE
Karl Edman · Timrå, SE
Johan Kajanus · Timrå, SE
Karl Anders Hogner · Timrå, SE
Philip Cornwall · Grafton, GB
Andrew Turner · Macclesfield, GB

Key dates

Filing date	Jun 29, 2015
Grant date	Jul 19, 2016
Priority date	—
Expiry date	Jun 29, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are certain derivatives of benzoxazinone amides of formula (I), or pharmaceutically acceptable salts thereof,that act as mineralocorticoid (MR) receptor modulators that may reduce oxidative stress in endothelium and hence improve vascular function, to methods for their potential therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.